These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Effects of immunosuppression on the efficacy of vaccination against Mycoplasma gallisepticum infection in chickens. Kulappu Arachchige SN; Kanci Condello A; Zhu L; Shil PK; Tivendale KA; Underwood GJ; Noormohammadi AH; Browning GF; Wawegama NK Vet Microbiol; 2021 Sep; 260():109182. PubMed ID: 34315003 [TBL] [Abstract][Full Text] [Related]
11. Field evaluation of tylosin premix in layers previously vaccinated with a live Mycoplasma gallisepticum vaccine. Evans RD; Trites JD; Cochrane RL Avian Dis; 2002; 46(1):208-14. PubMed ID: 11922337 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the short-term and long-term efficacies of the Mycoplasma gallisepticum vaccines ts-11 and 6/85. Noormohammadi AH; Whithear KG Avian Pathol; 2019 Jun; 48(3):238-244. PubMed ID: 30773899 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Mycoplasma gallisepticum (MG) ts-304 vaccine as a live attenuated vaccine in turkeys. Kanci A; Wijesurendra DS; Wawegama NK; Underwood GJ; Noormohammadi AH; Markham PF; Browning GF Vaccine; 2018 Apr; 36(18):2487-2493. PubMed ID: 29599086 [TBL] [Abstract][Full Text] [Related]
14. Age related differences in the immune response to vaccination and infection with Mycoplasma gallisepticum. Gaunson JE; Philip CJ; Whithear KG; Browning GF Vaccine; 2006 Mar; 24(10):1687-92. PubMed ID: 16288936 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Tylosin and Tilmicosin Against Experimental Garmyn A; Vereecken M; De Gussem K; Depondt W; Haesebrouck F; Martel A Avian Dis; 2019 Jun; 63(2):359-365. PubMed ID: 31251538 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of Mycoplasma gallisepticum TS-11 vaccine for the protection of layer pullets against challenge with virulent M. gallisepticum R-strain. Bíró J; Povazsán J; Korösi L; Glávits R; Hufnagel L; Stipkovits L Avian Pathol; 2005 Aug; 34(4):341-7. PubMed ID: 16147571 [TBL] [Abstract][Full Text] [Related]
18. Assessment of Mycoplasma gallisepticum vaccine efficacy in a co-infection challenge model with QX-like infectious bronchitis virus. Bwala DG; Solomon P; Duncan N; Wandrag DBR; Abolnik C Avian Pathol; 2018 Jun; 47(3):261-270. PubMed ID: 29451010 [TBL] [Abstract][Full Text] [Related]
19. Effects of live and killed vaccines against Mycoplasma gallisepticum on the performance characteristics of commercial layer chickens. Jacob R; Branton SL; Evans JD; Leigh SA; Peebles ED Poult Sci; 2014 Jun; 93(6):1403-9. PubMed ID: 24879690 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of a Mycoplasma gallisepticum oppD knockout mutant as a vaccine candidate. Tseng CW; Chiu CJ; Kanci A; Noormohammadi AH; Browning GF; Markham PF Vaccine; 2017 Oct; 35(45):6248-6253. PubMed ID: 28941621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]